Navigation Links
Researchers Make Headway in Treatment of Diabetic Retinopathy

Research has shown a way for people suffering diabetic retinopathy. The treatment envisaged assists in retarding as well as alleviating the effects of diabetic retinopathy,// which is by far the most common consequence of diabetes.

In the initial stages, retinopathy does not portray any visible symptoms but is capable of progressing gradually to cause the blood vessels of the eye to leak and break easily which ultimately could cause blindness. This complication is triggered by high blood glucose levels, almost all people suffering type 1 diabetes portray few symptoms of the disorder.

An in-depth article in the spring 2007 edition of Countdown, the quarterly journal of the Juvenile Diabetes Research Foundation, details ongoing human clinical trials in this area, and important findings that have been made to date. In the article, JDRF-funded scientists share valuable insights into the causes of retinopathy, as well as the therapeutics that are being developed as a result of the identification of new biological targets.

One study mentioned within the article was led by Dr. Lloyd Aiello of the Joslin Diabetes Center, who showed that the compound ruboxistaurin slowed the progress of retinopathy by inhibiting an enzyme in the body called protein kinase C beta (PKC beta), which is believed to contribute to the blood vessel damage that leads to the disease. This is the first time a drug has been shown to protect against the complication in a human clinical trial.

According to Dr. Richard Insel, Executive Vice President of Research for JDRF, "Since retinopathy is the most common and serious eye-related complication of those with type 1 and type 2 diabetes – and is the leading cause of adult blindness in Americans – the outstanding research being done in this area will have a significant impact on the millions of people with diabetes."

Source-Eurekalert/
'"/>




Page: 1

Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers trick Alzheimers Enzyme
4. Researchers find new HIV hiding place
5. New Hair in 15 Days Could Now Be A Possibility Say Researchers
6. Researchers developed world’s smallest toothbrus
7. Researchers discover receptor cells that can cause epilepsy
8. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
9. Researchers reversed the process of memory loss
10. Researchers Identify Key Gene That May Help Brain Treatment
11. Researchers Discover Protein That Causes Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... ... April 28, 2016 , ... ... Campaign for Tobacco-Free Kids, a leading force in the fight to reduce tobacco ... and local policies that can help reduce tobacco use. The initiative brings together ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... been collaborating with doctors and hospitals to make transformative changes in how health ... cell therapy minds this week in discussing breakthroughs in cellular medicine to treat ...
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... Amada Senior ... its newest office in San Antonio – its San Antonio West location. Prior to ... in medical device sales. The grand opening of Amada San Antonio West will take ...
(Date:4/28/2016)... Petaluma, Calif. (PRWEB) , ... April 28, 2016 ... ... equipment manufacturer specializing in the development of miniature microphones and headsets announced today ... modular headset design method of integrating in-earphones into a structure. This innovative design ...
(Date:4/28/2016)... ... ... Metabolic Nutrition today announced the upcoming launch of its revolutionary new ... and Sports Expo in Orlando, Florida. Attended by pro athletes, fitness enthusiasts, ... selected as the perfect event to introduce the highly anticipated GlycoLoad. , At ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... Dr. ... und Stephen Schmidt werden Teil ... ein führender Anbieter cloudbasierter Softwarelösungen für den ... neue Führungskräfte zum Team Sicherheit und Pharmakovigilanz ... Erfahrungen mitbringen.  Dies wird die Geschäftseinheit Sicherheit ...
(Date:4/28/2016)... JERUSALEM , April 28, 2016 ... ), a clinical-stage pharmaceutical company focused on the development of ... participate in the upcoming PIONEERS 2016 conference, presented by ... 5, 2016 in New York . ... overview at the conference. Presentation Details:   ...
(Date:4/27/2016)... April 27, 2016  Hologic, Inc. (Nasdaq: ... results for the fiscal second quarter ended March ... of $0.24 increased 41.2%, and non-GAAP diluted EPS ... increased 5.8% on a reported basis, and 6.3% ... "We posted another good quarter, highlighted by 14.6% ...
Breaking Medicine Technology: